NASDAQ · WGS
GeneDx Holdings Corp.
$68.07-$2.95 (-4.15%)
GeneDx Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.16% below the high.
Loading market information…
NASDAQ · TRHC · USD
Stock price, earnings
Quote as of Nov 2, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Tabula Rasa HealthCare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tabula Rasa HealthCare, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Tabula Rasa HealthCare, Inc. (TRHC) is an American healthcare technology company, operating through its CareVention HealthCare and MedWise HealthCare segments. The company develops and delivers a suite of cloud-based software and services aimed at optimizing medication management and improving patient care. Key offerings include EireneRx, an e-prescribing and medication decision-support platform, and MedWise, a medication therapy management (MTM) software designed to help identify and resolve drug-related issues. For precise dosing, they offer DoseMeRx, a decision support tool that leverages pharmacokinetic models and patient data. TRHC also provides comprehensive solutions for Programs of All-Inclusive Care for the Elderly (PACE), such as TruChart for electronic health records (EHR), care coordination, and financial oversight to track outcomes, and PACElogic, which integrates EHR, customer relationship management, claims processing, and care management workflows with regulatory reporting. PrescribeWellness serves as a patient engagement platform. Beyond software, the company offers clinical pharmacist collaboration, prescription fulfillment and adherence packaging, pharmacy benefit management (PBM), and health plan management services, including risk adjustment and third-party administration. As of December 31, 2021, TRHC's technology and services supported approximately 150 healthcare organizations, 350 health plans, and 18,000 retail pharmacies, providing valuable tools for prescribers and pharmacists. Founded in 2009, Tabula Rasa HealthCare, Inc. is headquartered in Moorestown, New Jersey.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2022 | May 5, 2022 | -$0.33-153.85% vs estimate | $67.11M |
|---|
| Q4 2021 | Feb 24, 2022 | -$0.09-12.5% vs estimate | $85.69M+0.58% vs estimate |
|---|
THE ANALYST VIEW
20 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$68.07-$2.95 (-4.15%)
GeneDx Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.16% below the high.
$23.69-$0.31 (-1.29%)
Claritev Corporation’s quoted price sits in the lower half of its reported 52-week range, 67.85% below the high.
$2.10-$0.10 (-4.55%)
SomaLogic, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.59% below the high.
$5.67$0.00 (0.0%)
scPharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.71% below the high.
$5.54-$0.01 (-0.18%)
Alimera Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.95% below the high.
$4.00+$0.01 (+0.25%)
Inozyme Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 35.9% below the high.
$6.00-$0.11 (-1.8%)
Monogram Orthopaedics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.61% below the high.
$5.38-$0.01 (-0.09%)
Third Harmonic Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.42% below the high.
